Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gundert-Remy

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranesS V Löser, J Meyer, S Freudenthaler, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosineC H Gleiter, S Freudenthaler, U Delabar, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Detection of drug side-effects in a Medical University Hospital]E Weber, U Gundert-Remy, K J Hahn, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatmentF Schlicht, C Staiger, J de Vries, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisolC Staiger, F Schlicht, E Walter, et al.
Critical Reviews in Toxicology|March 29, 2011
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol AJ G Hengstler, H Foth, T Gebel, et al.
MMW, Munchener Medizinische Wochenschrift|December 23, 1983
[Prescription figures and adverse effects of digitalis glycosides. A 2-year comparison of inpatients at a university hospital]B Czechanowski, R Baumann, R Ding, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 2003
The role of active metabolites in dihydrocodeine effectsH Schmidt, S V Vormfelde, M Walchner-Bonjean, et al.
Archives of Toxicology|December 20, 2002
Children as a sensitive subgroup and their role in regulatory toxicology: DGPT workshop reportM Schwenk, U Gundert-Remy, G Heinemeyer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1976
[Therapy of familial type II hyperlipoproteinemia in adults and children by means of sitosterin]P Oster, G Schlierf, C C Heuck, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranesS V Löser, J Meyer, S Freudenthaler, et al.
British Journal of Clinical Pharmacology|December 1, 1996
Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosineC H Gleiter, S Freudenthaler, U Delabar, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1972
[Detection of drug side-effects in a Medical University Hospital]E Weber, U Gundert-Remy, K J Hahn, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatmentF Schlicht, C Staiger, J de Vries, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisolC Staiger, F Schlicht, E Walter, et al.
Critical Reviews in Toxicology|March 29, 2011
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol AJ G Hengstler, H Foth, T Gebel, et al.
MMW, Munchener Medizinische Wochenschrift|December 23, 1983
[Prescription figures and adverse effects of digitalis glycosides. A 2-year comparison of inpatients at a university hospital]B Czechanowski, R Baumann, R Ding, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 1, 2003
The role of active metabolites in dihydrocodeine effectsH Schmidt, S V Vormfelde, M Walchner-Bonjean, et al.
Archives of Toxicology|December 20, 2002
Children as a sensitive subgroup and their role in regulatory toxicology: DGPT workshop reportM Schwenk, U Gundert-Remy, G Heinemeyer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1976
[Therapy of familial type II hyperlipoproteinemia in adults and children by means of sitosterin]P Oster, G Schlierf, C C Heuck, et al.
Pageof 13